comparemela.com

Latest Breaking News On - Isaac eliaz - Page 3 : comparemela.com

Electricity Holds Key to Chronic and Prescription-Resistant Pain, Experts Say

/PRNewswire/ Join DrTalks.com and the foremost authority in North America for PEMF therapy, Dr. William Pawluk, from Tuesday, July 12th to Wednesday, July.

New yorkUnited statesWilliam pawlukRiz lakhaniChristi simoneauxJoel fuhrmanMarlene mahipatKashif khanNew york timesSupercharge your health withNorth americaPulsed electromagnetic fieldHealing summitIsaac eliazSurvival paradoxHealth with

Eliaz Therapeutics Awarded $1 7 Million by NIH for XGAL3 s Apheresis Large Animal Safety Study

/PRNewswire/ Eliaz Therapeutics Inc (ETI), a therapeutic apheresis company, was awarded its second NIH grant, an SBIR phase 2 grant for $1.7M. ETI has.

Isaac eliazEliaz therapeutics incTherapeutics incEliaz therapeutics

Peptides: A Promising Alternative to Opioids

/PRNewswire/ Join DrSummits.com with the founder of BioReset Medical, Dr. Matthew Cook, from Tuesday, May 17th to Tuesday, May 23rd for the Peptide Summit 2..

Matthew cookHeather sandison maramaKent holtorf medical groupUniversity of washington school medicineUniversity of california san franciscoUniversity at buffaloBioreset medicalKent holtorfHoltorf medical groupHeather sandisonIsaac eliazSurvival paradoxPeptide summitReset medicalWashington schoolCalifornia san francisco

Peptides: A Promising Alternative to Opioids

/PRNewswire/ Join DrSummits.com with the founder of BioReset Medical, Dr. Matthew Cook, from Tuesday, May 17th to Tuesday, May 23rd for the Peptide Summit 2..

Matthew cookHeather sandison maramaKent holtorf medical groupUniversity of washington school medicineUniversity of california san franciscoUniversity at buffaloBioreset medicalKent holtorfHoltorf medical groupHeather sandisonIsaac eliazSurvival paradoxPeptide summitReset medicalWashington schoolCalifornia san francisco

Eliaz Therapeutics is Raising Capital to Develop its Therapeutic Apheresis Device to Treat Acute Kidney Injury

/PRNewswire/ Berkery Noyes Securities is pleased to announce it has been retained by Eliaz Therapeutics ("ETI"), developer of a groundbreaking,.

Lou greccoIsaac eliazBerkery noyesAndrew levitchPrnewswire berkery noyesSteven quinnNoyes coNoyes securitiesEliaz therapeuticsAcute kidney injuryManaging directorOyes amp co

vimarsana © 2020. All Rights Reserved.